| Amanda Robertson, APRN, CNP, PMHNP-BC | |
|
2701 W University Blvd, Durant, OK 74701-2997 | |
| (580) 740-4053 | |
| Not Available |
| Full Name | Amanda Robertson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 2701 W University Blvd, Durant, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306696067 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 217309 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Robertson, APRN, CNP, PMHNP-BC Po Box 1701, Kingston, OK 73439-1701 Ph: (580) 740-4053 | Amanda Robertson, APRN, CNP, PMHNP-BC 2701 W University Blvd, Durant, OK 74701-2997 Ph: (580) 740-4053 |
News Archive
"You have to win the battle against depression", "what counts is not surrendering" and "this is not a short road" are examples of conceptual metaphors typically used to describe experiences and issues associated with disorders like depression.
For the past 18 months, while I was undergoing intensive physical therapy and many neurological tests after a complicated head injury, my friends would point to a silver lining: "Now you'll be able to write about your own bills." After all, I'd spent the past decade as a journalist covering the often-bankrupting cost of U.S. medical care.
National Institutes of Health scientists report that a single dose of an experimental Ebola virus (EBOV) vaccine completely protects cynomolgus macaques against the current EBOV outbreak strain, EBOV-Makona, when given at least seven days before exposure, and partially protects them if given three days prior.
Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces the completion of enrolment in a global Phase III clinical trial called "BFORE," which is designed to assess the effectiveness and safety of BOSULIF (bosutinib) as a first-line treatment for patients with chronic phase Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML).
Lipocine Inc. announced today that in addition to its issued patents involving oral testosterone, it has recently filed two new patent applications in support of its oral testosterone product for hypogonadism, also known as low testosterone (low T). These applications cover Lipocine's novel oral testosterone product (LPCN 1021) being developed to overcome the issues with currently marketed topical, parenteral, and transdermal testosterone products.
› Verified 9 days ago
Darci Lynn Bowen, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1801 Chukka Hina, Durant, OK 74701 Phone: 580-920-2100 | |
Jodi Robinson, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1400 Bryan Dr, Suite 303, Durant, OK 74701 Phone: 580-931-2227 Fax: 580-931-2057 | |
Duncan Kovash, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1901 Chukka Hina, Durant, OK 74701 Phone: 580-920-2100 | |
Mrs. Jennifer Renee Nelson, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1708 Delivery Lane, Durant, OK 74701 Phone: 580-924-5622 Fax: 580-745-5060 | |
Mrs. Johnette L Routh, A.R.N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1400 Bryan Dr, #300, Durant, OK 74702 Phone: 580-924-1700 Fax: 580-924-1736 | |
Mrs. Jessica Laine Williams, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1400 Bryan Dr Ste 208, Durant, OK 74701 Phone: 580-920-9063 |